Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherArticle

In vitro pharmacological profile of KW-6356, a novel adenosine A2A receptor antagonist/inverse agonist

Yutaro Ohno, Michihiko Suzuki, Hidetsugu Asada, Tomoyuki Kanda, Mayumi Saki, Hikaru Miyagi, Mai Yasunaga, Chiyo Suno, So Iwata, Jun-ichi Saito and Shinichi Uchida
Molecular Pharmacology March 9, 2023, MOLPHARM-AR-2022-000633; DOI: https://doi.org/10.1124/molpharm.122.000633
Yutaro Ohno
1Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michihiko Suzuki
2Molecular Analysis Center, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidetsugu Asada
3Cell biology, Kyoto University, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoyuki Kanda
4R&D Planning Department, R&D Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayumi Saki
5Medical Affairs Department, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hikaru Miyagi
2Molecular Analysis Center, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mai Yasunaga
6CMC R&D Center, Production Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiyo Suno
7Medical Chemistry, Kansai Medical University, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
So Iwata
3Cell biology, Kyoto University, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-ichi Saito
2Molecular Analysis Center, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinichi Uchida
1Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shinichi.uchida.fd@kyowakirin.com
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

MOLPHARM-AR-2022-000633
DOI 
https://doi.org/10.1124/molpharm.122.000633
PubMed 
36894319

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online March 9, 2023.

Article Versions

  • You are currently viewing an Earlier version of this article (March 9, 2023 - 13:15).
  • earlier version (March 10, 2023 - 07:38).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2023 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yutaro Ohno1,
  2. Michihiko Suzuki2,
  3. Hidetsugu Asada3,
  4. Tomoyuki Kanda4,
  5. Mayumi Saki5,
  6. Hikaru Miyagi2,
  7. Mai Yasunaga6,
  8. Chiyo Suno7,
  9. So Iwata3,
  10. Jun-ichi Saito2, and
  11. Shinichi Uchida1,*
  1. 1Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  2. 2Molecular Analysis Center, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., Japan
  3. 3Cell biology, Kyoto University, Japan
  4. 4R&D Planning Department, R&D Division, Kyowa Kirin Co., Ltd., Japan
  5. 5Medical Affairs Department, Kyowa Kirin Co., Ltd., Japan
  6. 6CMC R&D Center, Production Division, Kyowa Kirin Co., Ltd., Japan
  7. 7Medical Chemistry, Kansai Medical University, Japan
  1. ↵* Corresponding Author:
    Shinichi Uchida, Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd., 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, N/A, 411-8731, Japan. E-mail: shinichi.uchida.fd{at}kyowakirin.com

Statistics from Altmetric.com

Article usage

Article usage: March 2023 to September 2023

AbstractFullPdf
Mar 20235240176
Apr 20233440159
May 202360653124
Jun 20233903036
Jul 20232521836
Aug 20231371722
Sep 20237786

Next
Back to top

In this issue

Molecular Pharmacology: 104 (4)
Molecular Pharmacology
Vol. 104, Issue 4
1 Oct 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In vitro pharmacological profile of KW-6356, a novel adenosine A2A receptor antagonist/inverse agonist
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

In vitro pharmacological profile of KW-6356

Yutaro Ohno, Michihiko Suzuki, Hidetsugu Asada, Tomoyuki Kanda, Mayumi Saki, Hikaru Miyagi, Mai Yasunaga, Chiyo Suno, So Iwata, Jun-ichi Saito and Shinichi Uchida
Molecular Pharmacology March 9, 2023, MOLPHARM-AR-2022-000633; DOI: https://doi.org/10.1124/molpharm.122.000633

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

In vitro pharmacological profile of KW-6356

Yutaro Ohno, Michihiko Suzuki, Hidetsugu Asada, Tomoyuki Kanda, Mayumi Saki, Hikaru Miyagi, Mai Yasunaga, Chiyo Suno, So Iwata, Jun-ichi Saito and Shinichi Uchida
Molecular Pharmacology March 9, 2023, MOLPHARM-AR-2022-000633; DOI: https://doi.org/10.1124/molpharm.122.000633
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics